Registry Study Evaluating Long-Term Effectiveness and Safety of Systemic Treatments for Moderate-to-Severe Alopecia Areata

What this Trial Is About

This research aims to collect and analyze information on systemic treatments used for alopecia areata, a condition that causes hair loss and affects patients quality of life. It focuses on patients with moderate-to-severe forms of alopecia areata who need more extensive treatments beyond localized therapies. The study is a long-term, multicenter, prospective, observational registry designed to gather real-world data on how these treatments work and their safety over time. Patients who have alopecia areata and are starting or currently using systemic treatments are included in this registry. The study does not assign any treatments but observes the outcomes as patients receive their prescribed therapies in routine clinical care. Data collection occurs at regular intervals of every 3 to 6 months, and the registry plans to follow each participant for at least 10 years to assess the long-term effectiveness and safety of these treatments. Participants will be involved in providing information through clinical assessments, including the Severity of Alopecia Tool SALT score, the Dermatology Life Quality Index DLQI, and the Alopecia Areata Symptom Impact Scale AASIS. These evaluations, along with epidemiological data, will be collected at baseline and throughout the follow-up period. Researchers will monitor treatment outcomes, quality of life impacts, and safety over the extended observation time to better understand systemic therapies for alopecia areata.

Systemic Treatments for Alopecia Areata Registry